Valvular heart disease occurs when one or more of the heart's valves are damaged, affecting the normal flow of blood through the heart. This condition can involve valve stenosis (narrowing of the valve opening) or valve regurgitation (leakage of the valve), both of which can impair heart function over time. Common causes include age-related changes, infections like endocarditis, or congenital defects. Symptoms of valvular heart disease may include fatigue, shortness of breath, and swelling in the legs. Treatment options vary based on the severity of the condition and may include medications to control symptoms or surgical interventions such as valve repair or replacement. Early detection and management are key to preventing more severe complications.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India